Hodostin

CAS No. 51-60-5

Hodostin ( NSC 93753 )

Catalog No. M14796 CAS No. 51-60-5

Neostigmine methyl sulfate is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 45 In Stock
200MG 54 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hodostin
  • Note
    Research use only, not for human use.
  • Brief Description
    Neostigmine methyl sulfate is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
  • Description
    Neostigmine methyl sulfate is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
  • Synonyms
    NSC 93753
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    51-60-5
  • Formula Weight
    334.39
  • Molecular Formula
    C13H22N2O6S
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 10 mM
  • SMILES
    C[N+](C)(C)C1=CC=CC(OC(N(C)C)=O)=C1.[O-]S(=O)(OC)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Huang TH, et al. Yao Xue Xue Bao. 1982 Jul;17(7):534-9.
molnova catalog
related products
  • Galanthaminone

    Galanthaminone is a cholinesterase (AChE) inhibitor?is used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments.

  • TTNPB

    TTNPB, a potent RAR agonist, inhibits binding of [3H]tRA of human RARα (IC50: 5.1 nM), β (IC50: 4.5 nM), and γ (IC50: 9.3 nM), respectively.

  • Rocuronium bromide

    Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action.